This year, The World Orphan Drug Congress USA will be accepting poster submissions for the conference taking place in Washington, DC on May 23-25, 2023.
We are developing this poster section at the conference to facilitate wider engagements within the rare disease space.
Themes for posters can include, but are not limited to the following categories:
Drug Discovery • Clinical Development • Rare Disease Advocacy • Patient Access • Pricing & Reimbursement • Rare Oncology • Commercialization • Artificial Intelligence • Real World Evidence/Data • Digital Health • Cell & Gene Therapies • Diagnosis • Early Access • Caregivers • Disease States • Global Market Access • Next Gen Therapies • Payers
All abstracts must be submitted for review by March 31, 2023. You will then be contacted by our team accordingly.
Those who fall into the below categories are encouraged to apply:
• Patient advocacy organization • Patient, individual • Researcher, Health Care Provider, Physician • Researchers within small biotech • Researchers within big pharma • Current Student (Master, PhD)
We will not be accepting submissions from:
• Service provider (anyone offering paid services, looking to do business development). If you are a service provider looking for exposure, you can learn about alternative opportunities by reaching out to Justin.Franks@Terrapinn.com